Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial
van der Aalst CM, Denissen SJAM, Vonder M, et al.
Journal:
Eur Heart J Cardiovasc Imaging

First published: October 20, 2024 DOI: 10.1093/ehjci/jeaa168
View
- Share
Articles
Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease
Shah NP, Mulder H, Lydon B, et al.
Journal:
Am Heart J

First published: October 16, 2024 DOI: 10.1016/j.ahj.2024.10.009
View
- Share
Articles
Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation
Nicholls SJ, Manmathan GP
Journal:
Atherosclerosis

First published: October 11, 2024 DOI: 10.1016/j.atherosclerosis.2024.118628
View
- Share
Articles
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases
Potere N, Bonaventura A, Abbate A
Journal:
Arterioscler Thromb Vasc Biol

First published: October 10, 2024 DOI: 10.1161/ATVBAHA.124.319980
View
- Share
Articles
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Carvalho PEP, Gewehr DM, Nascimento BR, et al.
Journal:
JAMA Cardiol

First published: October 9, 2024 DOI: 10.1001/jamacardio.2024.3216
View
- Share
Articles
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Fuster V, García-Álvarez A, Devesa A, et al.
Journal:
J Am Coll Cardiol

First published: October 8, 2024 DOI: 10.1016/j.jacc.2024.06.045
View
- Share
Articles
Within-person stability of lipoprotein(a) concentration
Ghouse J, Ahlberg G, Albertsen Rand S, et al.
Journal:
Eur Heart J

First published: October 8, 2024 DOI: 10.1093/eurheartj/ehae652
View
- Share
Articles
Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors
Gallo A, Le Goff W, Santos RD, et al.
Journal:
Eur J Clin Invest

First published: October 6, 2024 DOI: 10.1111/eci.14326
View
- Share
Articles
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)
Journal:
Lancet Diabetes Endocrinol

First published: October 3, 2024 DOI: 10.1016/S2213-8587(24)00221-3
View
- Share
Articles
Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials
Llewellyn A, Simmonds M, Marshall D, et al.
Journal:
Atherosclerosis

First published: September 28, 2024 DOI: 10.1016/j.atherosclerosis.2024.118598
View
- Share
Articles
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
Zahger D, Schwartz GG, Du W, et al.
Journal:
J Am Coll Cardiol

First published: September 10, 2024 DOI: 10.1016/j.jacc.2024.06.035
View
- Share
Articles
Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial
Gibson CM, Duffy D, Bahit MC, et al.
Journal:
Eur Heart J

First published: September 2, 2024 DOI: 10.1093/eurheartj/ehae614
View
- Share

1 2 3 4 5

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

van der Aalst CM, Denissen SJAM, Vonder M, et al.

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Articles

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Potere N, Bonaventura A, Abbate A

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Articles

Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors

Gallo A, Le Goff W, Santos RD, et al.

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Articles

Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials

Llewellyn A, Simmonds M, Marshall D, et al.

Articles

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

Zahger D, Schwartz GG, Du W, et al.

Articles

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial

Gibson CM, Duffy D, Bahit MC, et al.

Articles

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

van der Aalst CM, Denissen SJAM, Vonder M, et al.

Share

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Share

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Share

Articles

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Potere N, Bonaventura A, Abbate A

Share

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Share

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Share

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Share

Articles

Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors

Gallo A, Le Goff W, Santos RD, et al.

Share

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Share

Articles

Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials

Llewellyn A, Simmonds M, Marshall D, et al.

Share

Articles

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

Zahger D, Schwartz GG, Du W, et al.

Share

Articles

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial

Gibson CM, Duffy D, Bahit MC, et al.

Share